Skip to main content
SpringerLink
Log in

A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Salidroside (p-hydroxyphenethyl-beta-d-glucoside), which is present in all species of the genus Rhodiola, has been reported to have a broad spectrum of pharmacological properties. The present study, for the first time, focused on evaluating the effects of the purified salidroside on the proliferation of various human cancer cell lines derived from different tissues, and further investigating its possible molecular mechanisms. Cell viability assay and [3H] thymidine incorporation were used to evaluate the cytotoxic effects of salidroside on cancer cell lines, and flow cytometry analyzed the change of cell cycle distribution induced by salidroside. Western immunoblotting further studied the expression changes of cyclins (cyclin D1 and cyclin B1), cyclin-dependent kinases (CDK4 and Cdc2), and cyclin-dependent kinase inhibitors (p21Cip1 and p27Kip1). The results showed that salidroside inhibited the growth of various human cancer cell lines in concentration- and time-dependent manners, and the sensitivity to salidroside was different in those cancer cell lines. Salidroside could cause G1-phase or G2-phase arrest in different cancer cell lines, meanwhile, salidroside resulted in a decrease of CDK4, cyclin D1, cyclin B1 and Cdc2, and upregulated the levels of p27Kip1 and p21Cip1. Taken together, salidroside could inhibit the growth of cancer cells by modulating CDK4-cyclin D1 pathway for G1-phase arrest and/or modulating the Cdc2-cyclin B1 pathway for G2-phase arrest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ATCC:

American Tissue Culture Collection

CDK:

Cyclin-dependent kinase

CDKI:

Cyclin-dependent kinase inhibitor

CDK4:

Cyclin-dependent kinase 4

Cdc2:

Cell division cycle protein 2

Cip1:

Cdk-interacting protein1

Kip1:

Kinase inhibitor protein

MTT:

3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide

PI:

Propidium iodide

References

  • Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14:159–69.

    Article  CAS  PubMed  Google Scholar 

  • Chen X, Liu J, Gu X, Ding F. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats. Brain Res. 2008;1238:189–98.

    Article  CAS  PubMed  Google Scholar 

  • Coqueret O. Linking cyclins to transcriptional control. Gene. 2002;299:35–55.

    Article  CAS  PubMed  Google Scholar 

  • Foijer F, Delzenne-Goette E, Dekker M, Te Riele H. In vivo significance of the G2 restriction point. Cancer Res. 2007;67:9244–7.

    Article  CAS  PubMed  Google Scholar 

  • Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249–53.

    Article  CAS  PubMed  Google Scholar 

  • Goel HC, Bala M, Prasad J, Singh S, Agrawala PK, Swahney RC. Radioprotection by Rhodiola imbricata in mice against whole-body lethal irradiation. J Med Food. 2006;9:154–60.

    Article  CAS  PubMed  Google Scholar 

  • Ihenetu K, Qazzaz HM, Crespo F, Fernandez-Botran R, Valdes Jr R. Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia. Clin Chem. 2007;53:1315–22.

    Article  CAS  PubMed  Google Scholar 

  • Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006;20:424–5.

    Article  CAS  PubMed  Google Scholar 

  • Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287–301.

    Article  CAS  PubMed  Google Scholar 

  • Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927–41.

    Article  PubMed  Google Scholar 

  • Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, et al. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res. 2005;19:740–3.

    Article  CAS  PubMed  Google Scholar 

  • Mishra KP, Padwad YS, Dutta A, Ganju L, Sairam M, Banerjee PK, et al. Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phase. Immunobiology. 2008;213:125–31.

    Article  CAS  PubMed  Google Scholar 

  • Nagini S. Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise? Anticancer Agents Med Chem. 2008;8:313–21.

    Article  CAS  PubMed  Google Scholar 

  • Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007;21:37–43.

    Article  CAS  PubMed  Google Scholar 

  • Pooja D, Bawa AS, Khanum F. Anti-inflammatory activity of Rhodiola rosea–"a second-generation adaptogen". Phytother Res. 2009;23:1099–102.

    Article  Google Scholar 

  • Schriner SE, Abrahamyan A, Avanessian A, Bussel I, Maler S, Gazarian M, et al. Decreased mitochondrial superoxide levels and enhanced protection against paraquat in Drosophila melanogaster supplemented with Rhodiola rosea. Free Radic Res. 2009;43:836–43.

    Article  CAS  PubMed  Google Scholar 

  • Skopińska-Rózewska E, Malinowski M, Wasiutyński A, Sommer E, Furmanowa M, Mazurkiewicz M, et al. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci. 2008;11:97–104.

    PubMed  Google Scholar 

  • Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. Double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000;7:85–9.

    CAS  PubMed  Google Scholar 

  • Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, et al. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther. 2008;7:10–8.

    Article  CAS  PubMed  Google Scholar 

  • Takagaki N, Sowa Y, Oki T, Nakanishi R, Yogosawa S, Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol. 2005;26:185–9.

    CAS  PubMed  Google Scholar 

  • Udintsev SN, Shakhov VP. The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma. 1991;38:323–31.

    CAS  PubMed  Google Scholar 

  • Vickers AJ. Which botanicals or other unconventional anticancer agents should we take to clinical trial? J Soc Integr Oncol. 2007;5:125–9.

    Article  PubMed  Google Scholar 

  • Wang H, Ding Y, Zhou J, Sun X, Wang S. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine. 2009;16:146–55.

    Article  PubMed  Google Scholar 

  • Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, et al. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev. 2009;18:331–41.

    Article  CAS  PubMed  Google Scholar 

  • Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005;65:1035–44.

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C, et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2007;564:18–25.

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Liu A, Hou R, Zhang J, Jia X, Jiang W, et al. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol. 2009;607:6–14.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was partly supported by a grant from Medicine Health Science Research Fund of PLA (No: 01L003) and was supported in part by a grant awarded to Zhejiang Provincial Natural Science Foundation (Y2080271).

Author information

Authors and Affiliations

  1. Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, 388Yuhangtang Road, Hangzhou, 310058, Zhejiang, China

    Xiaolan Hu, Shuifeng Qiu, Xianqi Zhang & Ruhuan Mei

  2. Department of Pathophysiology, Fourth Military Medical University, Xi’an, China

    Shuxin Lin & Daihua Yu

Authors
  1. Xiaolan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuxin Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daihua Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuifeng Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xianqi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruhuan Mei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaolan Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, X., Lin, S., Yu, D. et al. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol Toxicol 26, 499–507 (2010). https://doi.org/10.1007/s10565-010-9159-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10565-010-9159-1

Keywords

Search

Navigation